High T cell responses to the glutamic acid decarboxylase (GAD) isoform 67 reflect a hyperimmune state that precedes the onset of insulin-dependent diabetes

Journal of Autoimmunity

Volumn 10, Issue 2, 1997, Pages 165-173

  Honeyman, Margo C ^a   Stone, Natalie ^c   De Aizpurua, Henry ^a   Rowley, Merrill J ^b   Harrison, Leonard C ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c NONE

Author keywords

antibody; first degree relative; glutamic acid decarboxylase (GAD); insulin; insulin dependent diabetes mellitus; islet cell antibody (ICA); T cell

Indexed keywords

GLUTAMATE DECARBOXYLASE;

ADOLESCENT; ADULT; ANTIBODY RESPONSE; ARTICLE; AUTOIMMUNITY; CELLULAR IMMUNITY; CHILD; CLINICAL ARTICLE; FEMALE; HUMAN; IMMUNOPATHOGENESIS; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PRIORITY JOURNAL; RELATIVE; T LYMPHOCYTE;

EID: 0031127957     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1996.0124     Document Type: Article

References (31)

1. 1. Bonifacio E., Bingley P.J., Shattock M., Dean B.M., Dunger D., Gale E.A., Bottazzo G.F. 1990. Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes. Lancet 335: 147-149
2. 2. Palmer J.P., Asplin C.M., demons P., Lyen K., Tatpati O., Raghu P.K., Paquette T.L. 1983. Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 222: 1337-1339
3. 3. DeAizpurua H.J., Wilson Y.M., Harrison L.C. 1992. Glutamic acid decarboxylase autoantibodies in preclinical insulin-dependent diabetes. Proc. Natl. Acad. Sci. USA. 89: 9841-9845
4. 4. Bonifacio E., Genovese S., Ferrari M., Bosi E. 1995. Identification of protein tyrosine phosphatase-like IA-2 (islet cell antigen 512) as the insulin dependent diabetes-related 37/40K autoantigen and a component of islet cell antibodies. J. Immunol. 155: 6519-6526
5. 5. Bingley P.J., Christie M.R., Bonifacio E., Bonfanti A., Shattock M., Fonte M.T., Bottazzo G.F., Gale E.A. 1994. Combined analysis of autoantibodies improves prediction of IDDM in islet-cell antibody-positive relatives. Diabetes 43: 1304-1310
6. 6. Bingley P.J., Bonifacio E., Gale E.A. 1991. Can we really predict IDDM? Diabetes 42: 213-220
7. 7. Honeyman M.C., Harrison L.C. 1993. The immunologic insult in type 1 diabetes. Springer Semin. Immunopathol. 14: 253-274
8. 8. Bottazzo G.F., Dean B.M., McNally J.M., MacKay E.H., Swift P.G., Gamble D.R. 1985. In situ characterisation of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulin's. N. Engl. J. Med. 313: 353-360
9. 9. Itoh N., Hanafusa T., Miyazaki A., Miyagawa J., Yamagata K., Yamamoto K., Waguri M ., Imagawa A., Tamura S., Inada M 1993. Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients. J. Clin. Invest. 92: 2313-2322
10. 10. Harrison L.C., De Aizpurua H., Loudovaris T., Campbell I.L., Cebon J.S., Tait B.D., Colman P.G. 1991. Responses to human islets and fetal pig proislets by peripheral blood mononuclear cells from relatives with preclinical and clinical insulin-dependent diabetes. Diabetes 40: 1128-1133
11. 11. Harrison L.C., Chu S.X., De Aizpurua H.J., Graham M., Honeyman M.C., Colman P.G. 1992. Islet-reactive T cells are a marker of preclinical insulin-dependent diabetes. J. Clin. Invest. 89: 1161-1165
12. 12. Atkinson M.A., Kaufman D.L., Campbell L., Gibbs K.A., Shah S.C., Bu D.F., Erlander M.G., Tobin A.J., Maclaren N.K. 1992. Response of peripheral-blood mononuclear cells to glutamate decarboxylase in insulin-dependent diabetes. Lancet 339: 458-459
13. 13. Honeyman M.C., Cram D.S., Harrison L.C. 1993. Glutamic acid decarboxylase 67-reactive T cells: a marker of insulin-dependent diabetes. J. Exp. Med. 177: 535-540
14. 14. Schmidli R.S., Colman P.G., Bonifacio E., Bottazzo G.F., Harrison L.C. 1994. High level of concordance between assays for glutamic acid decarboxylase antibodies. The First International GAD Antibody Workshop. Diabetes 43: 1005-1009
15. 15. Cram D.S., Barnett L.D., Joseph J.L., Harrison L.C. 1991. Cloning and partial nucleotide sequence of human glutamic acid decarboxylase cDNA from brain and pancreatic islets. Biochem. Biophys. Res. Comm. 176: 1239-1244
16. 16. Kwok W.W., Domeier M.E., Raymond F.C., Byers P., Nepom G.T. 1996. Allele-specific motifs characterize HLA-DQ interactions with a diabetes-associated peptide derived from glutamic acid decarboxylase. J. Immunol. 156: 2171-2177
17. 17. Bosi E., Bazzigaluppi E., Pastore M.R., Bonfanti R., Balini A., Dozio N., Belloni C., Bonifacio E. 1996. Multiple islet autoantibody screening for IDDM risk assessment in first-degree relatives. Autoimmunity 24(suppl 1): 54
18. 18. Verge C.F., Gianani R., Kawasaki E., Yu L., Pietropaolo M., Jackson R.A., Chase H.P., Eisenbarth G.S. 1996. Prediction of type 1 diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512/IA-2 autoantibodies. Diabetes 45: 926-933
19. 19. Honeyman M.C., Harrison L.C., Drummond B., Colman P.G., Tait B.D. 1995. Analysis of families at risk for insulin-dependent diabetes mellitus reveals that HLA antigens influence progression to clinical disease. Mol. Med. 1: 576-582
20. 20. Thomson G., Robinson W.P., Kuhner M.K., Joe S., MacDonald M.J., Gottschall J.L., Barbosa J., Rich S.S., Bertrams J., Baur M.P., Partanen J., Tait B.D., et al. 1988. Genetic heterogeneity, modes of inheritance, and risk estimates for a joint study of Caucasians with insulin-dependent diabetes mellitus. Am. J. Hum. Genet. 43: 799-816
21. + first degree relatives of patients with type 1 diabetes expressing the HLA-DQB1*0602 allele. J. Autoimmun. 9: 423-425.
22. 22. Tisch R., Yang X.C., Singer S.M., Liblau R.S., Fugger L., McDevitt H.O. 1993. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature 366: 72-75
23. 23. De Aizpurua H.J., French M.B., Chosich N., Harrison L.C. 1994. Natural history of humoral immunity to glutamic acid decarboxylase in non-obese diabetic (NOD) mice. J. Autoimmun. 7: 643-653
24. 24. Schmidli R.S., De Aizpurua H.J., Harrison L.C., Colman P.G. 1994. Antibodies to glutamic acid decarboxylase in at-risk and clinical insulin-dependent diabetic relatives: relationship to age, sex and islet cell antibody status, and temporal profile. J. Autoimmun. 7: 55-66
25. 25. Harrison L.C., Honeyman M.C., De Aizpurua H.J., Schmidli R.S., Colman P.G., Tait B.D., Cram D.S. 1993. Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in relatives at risk of insulin-dependent diabetes. Lancet 341: 1365-1369
26. 26. Li S., Quayle A.J., Thoen J.E., Forre O.T. 1996. Superantigen-mediated proliferation and cytotoxicity of T cells isolated from the inflammatory tissues and peripheral blood of arthritis patients. Clin. Immunol. Immunopathol 79: 278-287
27. 27. Rudy G., Stone N., Harrison L.C., Colman P.G., McNair P., Brusic V., French M., Honeyman M.C., Tait B.D., Lew A.M. 1995. Similar peptides from two β cell autoantigens, proinsulin and glutamic acid decarboxylase, stimulate T cells of individuals at risk for insulin-dependent diabetes. Mol. Med. 1: 625-633
28. 28. Shimada A., Charlton B., Taylor-Edwards C., Fathman C.G. 1996. Beta-cell destruction is a late consequence of the autoimmune process in NOD mice. Autoimmunity 24(suppl 1): 34
29. 29. Gazda L., Charlton B., Lafferty K.J. 1996. Islet β-cell destruction in IDDM: an acute event in a chronic autoimmune disease. Autoimmunity 24(suppl 1): 37
30. 30. Atkinson M.A., Bowman M.A., Campbell L., Darrow B.L., Kaufman D.L., Maclaren N.K. 1994. Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes. J. Clin. Invest. 94: 2125-2129
31. 31. Kaufman D.L., Clare-Salzler M., Tian J., Forsthuber T., Ting G.S., Robinson P., Atkinson M.A., Sercarz E.E., Tobin A.J., Lehmann P.V. 1993. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature 366: 69-72